BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 4950744)

  • 1. When to discontinue oral contraceptives.
    Board JA
    Va Med Mon (1918); 1970 Oct; 97(10):623-7. PubMed ID: 4950744
    [No Abstract]   [Full Text] [Related]  

  • 2. Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina.
    Sperling MA
    West J Med; 1975 Jan; 122(1):42-9. PubMed ID: 1089006
    [No Abstract]   [Full Text] [Related]  

  • 3. [Oral estro-progestational agents and the uterine cervix].
    de Brux J
    Pathol Eur; 1972; 7(3):283-7. PubMed ID: 4657185
    [No Abstract]   [Full Text] [Related]  

  • 4. How dangerous are oral contraceptives?
    Jordaan HV
    S Afr Med J; 1972 Aug; 46(34):1215-7. PubMed ID: 5056771
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral contraceptives: relations to mammary cancer, benign breast lesions, and cervical cancer.
    Drill VA
    Annu Rev Pharmacol; 1975; 15():367-85. PubMed ID: 1096791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives: clinical problems and choices.
    Jones DE; Halbert DR
    Am Fam Physician; 1975 Oct; 12(4):115-23. PubMed ID: 1163414
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oral contraception and cancers of the uterus and the breast].
    Vokaer R
    J Gynecol Obstet Biol Reprod (Paris); 1974; 3(3):379-400. PubMed ID: 4470735
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental and clinical aspects of the carcinogenic potential of steroid contraceptives.
    Hertz R
    Int J Fertil; 1968; 13(4):273-86. PubMed ID: 4882601
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumorigenic aspects.
    Kirk ME
    Int J Gynaecol Obstet; 1978-1979; 16(6):473-8. PubMed ID: 39811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lesions of the uterine cervix during oral contraception].
    De Brux J
    Sem Hop; 1974 May; 50(22):1491-5. PubMed ID: 4369604
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical evaluation of side effects of current oral contraceptives.
    Nelson JH
    J Reprod Med; 1971 Feb; 6(2):50-5. PubMed ID: 4255975
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormonal contraceptives].
    Martínez-Manautou J; Giner J
    Gac Med Mex; 1970 Oct; 100(10):993-1026. PubMed ID: 4943137
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral contraception. Physiologic and pathologic effects.
    Andrews WC
    Obstet Gynecol Annu; 1978; 7():325-51. PubMed ID: 351485
    [No Abstract]   [Full Text] [Related]  

  • 14. Complications of oral contraceptives--a symposium. Liver disease and abnormalities of laboratory tests.
    Fisher DA
    West J Med; 1975 Jan; 122(1):40-2. PubMed ID: 162817
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of oral contraceptives to cervical carcinogenesis.
    Thomas DB
    Obstet Gynecol; 1972 Oct; 40(4):508-18. PubMed ID: 5073446
    [No Abstract]   [Full Text] [Related]  

  • 16. [The general side effects of oral contraceptives].
    Pyörälä T
    Duodecim; 1973 Oct; 89(24):1626-35. PubMed ID: 4589251
    [No Abstract]   [Full Text] [Related]  

  • 17. Folate for oral contraceptive users may reduce cervical cancer risk.
    Check WA
    JAMA; 1980 Aug; 244(7):633-4. PubMed ID: 7392160
    [No Abstract]   [Full Text] [Related]  

  • 18. Cervical carcinoma and oral contraception.
    Boyce JG; Lu T; Nelson JH; Joyce D
    Obstet Gynecol; 1972 Aug; 40(2):139-46. PubMed ID: 5047946
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer risks from estrogen intake.
    Greenwald P; Nasca PC; Caputo TA; Janerich DT
    N Y State J Med; 1977 Jun; 77(7):1069-74. PubMed ID: 267252
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral contraceptives and the skin.
    Jelinek JE
    Am Fam Physician; 1971 Nov; 4(5):68-74. PubMed ID: 4330118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.